Literature DB >> 16552172

Using immunotherapy to target EGF in patients with NSCLC.

Deirdre O'Mahony1, Phillip A Dennis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552172     DOI: 10.4161/cbt.5.2.2557

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  1 in total

1.  APRIL promotes non-small cell lung cancer growth and metastasis by targeting ERK1/2 signaling.

Authors:  Hengli Dou; Zhaohua Yan; Meng Zhang; Xiaoxin Xu
Journal:  Oncotarget       Date:  2017-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.